<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Iran J Child Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Iran J Child Neurol</journal-id>
<journal-id journal-id-type="publisher-id">IJCN</journal-id>
<journal-title-group>
<journal-title>Iranian Journal of Child Neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1735-4668</issn>
<issn pub-type="epub">2008-0700</issn>
<publisher>
<publisher-name>Shahid Beheshti University of Medical Sciences</publisher-name>
<publisher-loc>Tehran, Iran</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31645865</article-id>
<article-id pub-id-type="pmc">6789083</article-id>
<article-id pub-id-type="publisher-id">ijcn-13-037</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Feature and Genetics in Rett Syndrome: A Report on Iranian Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>KARIMZADEH</surname>
<given-names>Parvaneh</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>KHEIROLLAHI</surname>
<given-names>Majid</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>HOUSHMAND</surname>
<given-names>Seyed Massoud</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DADGAR</surname>
<given-names>Sepideh</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>ARYANI</surname>
<given-names>Omid</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>YAGHINI</surname>
<given-names>Omid</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<bold>Pediatric Neurology ResearchCenter, Research Institute forChildren’s Health, Shahid Beheshti University of MedicalSciences, Tehran, Iran</bold>
</aff>
<aff id="aff2">
<label>2</label>
<bold>Pediatric NeurologyDepartment, Mofid Children’s Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</bold>
</aff>
<aff id="aff3">
<label>3</label>
<bold>Department of Medical Genetics, Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan, Iran.</bold>
</aff>
<aff id="aff4">
<label>4</label>
<bold> Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</bold>
</aff>
<aff id="aff5">
<label>5</label>
<bold>Department of Medical Genetic Medical Center and Faculty, Member of NIGEB, Tehran, Iran</bold>
</aff>
<aff id="aff6">
<label>6</label>
<bold>Pediatric Neurology, Child growth and Development research center, Research Institute for Primordial Prevention of Noncommunicable Disease of Medical Genetic, Isfahan University of Medical Sciences. Isfahan, Iran.</bold>
</aff>
<author-notes>
<corresp id="cor">Corresponding Author: Yaghini O. MD, Pediatric Neurology, Child growth and Development research center, Research Institute for Primordial Prevention of Noncommunicable Disease of Medical Genetic, Isfahan University of Medical Sciences. Isfahan, Iran. Email: yaghini@med.mui.ac.ir</corresp>
</author-notes>
<pub-date pub-type="ppub">
<season>Autumn</season>
<year>2019</year>
</pub-date>
<volume>13</volume>
<issue>4</issue>
<fpage>37</fpage>
<lpage>51</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<license license-type="open-access">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>Rett syndrome is characterized by normal development for the first 6-18 months of life followed by the loss of fine and gross motor skills and the ability to engage in social interaction. In most patients, mutations are found in methyl CpG-binding protein 2 (MECP2) gene. We investigated the relation between Rett clinical diagnosis and mutations in MECP2. </p>
</sec>
<sec>
<title>Materials &amp; Methods</title>
<p>Children suspected of Rett syndrome were invited to participate in this study. Twenty-three patients from the Mofid Hospital, Tehran, Iran suffered from classic Rett syndrome diagnostic criteria were enrolled in 2012. The severity of symptoms was assessed for all of them. The peripheral blood samples were collected in EDTA tubes and the genomic DNA was extracted using standard salting out method. The mutation of MEPC2 gene was studied using DNA sequencing method. </p>
</sec>
<sec>
<title>Results</title>
<p>Overall, 11(47.8%) patients had MECP2 gene mutation, while 12 cases (52.2%) had no mutations. Changes in genetics were associated with phenotypical manifestations. The most prevalent mutation was p.v288 mainly associated with partially or uncontrolled seizures. </p>
</sec>
<sec>
<title>Conclusion</title>
<p>For the first time, we studies the Rett syndrome in terms of clinical manifestations and genetic changes in Iran.</p>
</sec>
</abstract>
<kwd-group>
<title>Key Words</title>
<kwd>Rett Syndrome</kwd>
<kwd>MECP2</kwd>
<kwd>Genetics</kwd>
<kwd>Iran</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Rett syndrome is a X-linked progressive brain developmental disorder and one of the most common causes of mental retardation in females first described in the 1960s by Andreas Rett (<xref ref-type="bibr" rid="B1">1</xref>). Girls affected with classic form of Rett syndrome (RTT) seem to have normal development for 6 to 18 months. This course then followed by the loss of acquired fine and gross motor skills and the ability to engage in social interaction. Abnormal stereotypic hand movements may also occur. Rett syndrome primarily affects females and has an incidence of 1:10000 at birth until the age of 12 years (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Rett syndrome has two main types: classic and atypical. These two types may be characterized by their symptoms or specific gene mutations, and most patients with Rett syndrome have a classic form (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>Mutations in the X-linked gene methyl CpG-binding protein 2 (MECP2) have been found in the majority of patients. MeCP2 is a protein that is critical for normal brain function. This protein is involved in maintaining synapses between nerve cells (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>The mutations in the gene encoding <italic>MECP2 </italic>are associated with rare familial cases of RTT as well as in the usual sporadic cases of typical RTT (<xref ref-type="bibr" rid="B4">4</xref>). Using modern mutation detection tests, n 70%-80% of patients with typical RTT mutations are found in <italic>MECP2 </italic>(<xref ref-type="bibr" rid="B5">5</xref>). In addition to RTT, mutations in <italic>MECP2 </italic>have also been identified in cases with no clinical features of RTT. </p>
<p>Mutations are in the X-linked gene MECP2, which encodes MeCP2 protein. MeCP2 is a member of family of methyl-CpG-binding domain proteins (MBD), but with their unique differences that help put it apart from the group. More than 600 MECP2 mutations have been identified, including missense, nonsense, frameshift and large deletion mutations that are pathogenic effect (RettBase; http://mecp2.chw.edu.au/). Most of these changes in MECP2 gene cause RTT in heterozygous females, but there is allelic heterogeneity in this disorder and a range of MECP2 mutations associated with variable phenotypic outcomes, including milder forms of learning disability and, rarely, autism, are also known (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>
<italic>MECP2</italic> has two functional domains, a methyl-cytosine-binding domain (MBD) with composition of 85 amino acids and a transcriptional repression domain (TRD) which has 103 amino acids. The MBD domain binds to the methylation sites of CpG in the DNA strands and then TRD region makes reaction with SIN3A to utilize histone deacetylases (HDAC). There are also two high mobility group protein-like domains. The unusual, repetitive sequences are found at the carboxyl terminus (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>At one end of the spectrum, asymptomatic female carriers are found in familial RTT (<xref ref-type="bibr" rid="B11">11</xref>). Skewing of X chromosome inactivation (XCI) in these individuals allows them to have a normal presentation. At the other end of spectrum, boys with <italic>MECP2 </italic>mutations are confronted with severe early postnatal encephalopathy, early death, and absence of the distinctive clinical features of RTT (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>In addition to <italic>MECP2</italic> mutations, cyclin-dependent kinase-like 5 (CDKL5) and Netrin G1, two other genes have recently been known in patients with clinical phenotype of Rett syndrome (<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>At present, a variety of clinical trials are done in RTT. As suggested in previous comprehensive studies conducted by Rett Search Consortium, clinical trials and other research studies to use a set of guidelines for classifying the disease (<xref ref-type="bibr" rid="B15">15</xref>). First, all individuals should be carefully reviewed and categorized clinically based on revised clinical criteria. The clinical diagnosis for all participants should be clearly stated in each publication. Second, comprehensive and complete genetic testing for mutations in <italic>MECP2 </italic>should be performed for all participants. This would include the sequencing of the coding region (<xref ref-type="bibr" rid="B15">15</xref>). </p>
<p>We felt that Rett syndrome patients were not well studied in Iran. Therefore, we examined these patients based on the two main principals mentioned above to determine the spectrum of mutation in patients with Rett syndrome.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and Methods</title>
<p>
<bold>Patients and samples</bold>
</p>
<p>Twenty-three female children suspected of Rett syndrome referred to Neurology Outpatient Clinic, Mofid Hospital, Tehran, Iran in 2012 were invited to take part in this study. Referred individuals should have had a history of a period of relatively normal development after birth, followed by regression of developmental skills including the use of volitional hand, as well as reduced the speed of head circumference growth. The patients were enrolled in this study after observing the diagnostic criteria of classic Rett syndrome. The diagnosis of RTT was based exclusively on a set of clinical criteria derived from expert consensus (<xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="B15">15</xref>). </p>
<p>All examinations were performed by an expert pediatric neurologist. If any of them did not cooperate in the ongoing research, they were excluded from the study. For all included patients, severity of symptoms was assessed by a questionnaire. Locomotion, onset of signs and symptoms, seizure, head circumference growth, thrive, hand use, communication abilities, autonomic system disorders, EEG, scoliosis and self-abuse were graded from 0 to 3 to reflect severity of the signs and symptoms (<xref ref-type="table" rid="T2">Table 2</xref>). </p>
<p>Informed consent was obtained from all the parents of patients for participation in this study.</p>
<p>
<bold><italic>Molecular Methods</italic></bold>
</p>
<p>
<italic>MEPC2</italic> gene mutation was studied by DNA sequencing method. We collected blood sample from suspected patients referred to genetic laboratory. The genomic DNA was extracted from peripheral blood in EDTA tubes by standard salting out method. DNA purity was assessed with a spectrophotometer and calculated by ratio of the DNA optical density (OD 260) and protein optical density (OD 280). DNA yield was calculated from DNA optical density (OD 260) for clean DNA samples. To avoid errors derived from <italic>Taq</italic> PCR polymerase, PCR was performed using PFU DNA polymerase (Fermentas, St. Leon-Rot, Germany). Finally, the reaction products were sequenced and examined by Chromas program.</p>
<p>
<bold><italic>Statistics</italic></bold>
</p>
<p>Having gathered patients’ data and molecular results, descriptive correlation between genotype and phenotype was finally investigated.</p>
</sec>
<sec sec-type="results">
<title>Results</title>
<p>Of 27 patients who met the inclusion criteria, 23 accepted to participate in the study. The mean age of 23 included patients in study was 5.2 yr with SD: ±2.13. The minimum and maximum age was 2, and 10 yr, respectively. The age of onset for signs and symptoms was ranged mostly less than 18 months (87%) and only 3 of 23 patients (13%) had shown their signs and symptoms in the range of 18-30 months. According to the chart brought in methods section, the severity of signs and symptoms were defined from 0 (less sever) to 3 (most sever) pluses (<xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p>In addition, frequencies for each of signs or symptoms were calculated. Of 23 included patients, 3 could walk without help, 12 needed help, 4 needed devices to walk and 4 were disabled. Five patients were affected by uncontrolled Seizure, 4 had partially controlled and 9 had controlled seizure, meanwhile five Rett syndrome patients had not any complaint of seizure. Head circumference, thrive, hand use, communication abilities, autonomic system disorders, EEG, Scoliosis and self-abuse descriptive results are brought in <xref ref-type="table" rid="T4">Table 4</xref>. Regarding <italic>MECP2</italic> gene mutation, 11 patients (47.8% of total included patients) had this mutation meanwhile 12 (52.2%) had no mutation.</p>
<p>Of all 13 patients who showed epilepsy, <italic>MECP2</italic> positive patients were more prone to have epilepsy. Eight epileptic patients had <italic>MECP2</italic> mutation and the remaining 5 had not any evidence for <italic>MECP2</italic> mutation. However, severity of epilepsy (uncontrolled seizures) was not related to <italic>MECP2</italic>. Similar results were seen in EEG abnormalities.</p>
<p>Hand use, psychomotor retardation and communication problems were seen in all patients either in <italic>MECP2</italic> positives or negatives. Autonomic dysfunction was seen in 7 patients that only one of them had <italic>MECP2</italic> mutation and other 6 ones had no evidence of mutation.</p>
<p>
<italic>MEPC2</italic> gene mutation was studied for each patient too. Ten patients showed evidence of nucleotide changes including missense, nonsense or frameshift. The rest of patients did not show any evidence of changes. The detail of the changes detected for each patient is brought in <xref ref-type="table" rid="T5">Table 5</xref> and <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<p>Change in genetics is in association with phonotypical manifestations. The most prevalent mutation was p.v288 which is mostly in association with partially or uncontrolled seizures. Moreover, the patients affected with this mutation show severe EEG abnormalities. In addition, we found new frameshift mutation in this study.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Rett syndrome diagnostic criteria</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" colspan="3" rowspan="1">Requirements<break></break>Consider diagnosis when postnatal deceleration of head growth obseved</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Required for typical or classic RTT</th>
<th align="left" colspan="2" rowspan="1">Required for atypical or variant RTT</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1.A period of regression followed by recovery or stabilization<break></break>2.All main criteria and all exclusion criteria<break></break>3.supportive criteria are not required.although often present in typical RTT</td>
<td align="left" colspan="2" rowspan="1">1.A period of regression followed by recovery or stabilization<break></break>2.at least 2 of the 4 main criteria<break></break>3.5out of 11 supportive criteria</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Criteria</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Main criteria</td>
<td align="left" colspan="2" rowspan="1">1. Partial or complete loss of aquired purposeful hand skills<break></break>2. Partial or complete loss of aquired spoken language<break></break>3. Gait abnormalities:impaired or absence of ability<break></break>4. Stereotypic hand movements such as hand writing/squeezing, clapping/tapping,mouthing and washing/rubbing automatism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exclusion criteria for typical RTT</td>
<td align="left" colspan="2" rowspan="1">1.Brain injury secondary to trauma(peri- or postnataly),neurometabolic disease,or sever infection that causes neurological problems<break></break>2.Grossly abnormal psychomotor development in first 6 months of life</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Supportive criteria for atypical RTT</td>
<td align="left" colspan="1" rowspan="1">1. Breathing disturbance when awake<break></break>2. Bruxism when awake<break></break>3. Impaired sleep pattern<break></break>4. Abnormal muscle tone<break></break>5. Peripheral vasomotor distrurbance<break></break>6. scoliosois/kyphosis</td>
<td align="left" colspan="1" rowspan="1">7. Growth retardation<break></break>8. Small cold hands and feet<break></break>9. Inappropriate laughing/screaming spells<break></break>10. Diminshed response to pain<break></break>11. Intense eye communication”eye pointing”</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Signs and Symptoms severity assessment questionnaire</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle"></th>
<th align="left" colspan="1" rowspan="1" valign="middle">0</th>
<th align="left" colspan="1" rowspan="1" valign="middle">1 plus</th>
<th align="left" colspan="1" rowspan="1" valign="middle">2 pluses</th>
<th align="left" colspan="1" rowspan="1" valign="middle">3 pluses</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle">Signs and Symptoms age of onset</th>
<th align="left" colspan="1" rowspan="1" valign="middle">No</th>
<th align="left" colspan="1" rowspan="1" valign="middle">After 30 months</th>
<th align="left" colspan="1" rowspan="1" valign="middle">18-30 months</th>
<th align="left" colspan="1" rowspan="1" valign="middle">Less than 18 months</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Locomotion</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Without help</td>
<td align="left" colspan="1" rowspan="1" valign="middle">With help</td>
<td align="left" colspan="1" rowspan="1" valign="middle">With device</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Disable to walk</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Seizure</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Under control</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Partially controlled</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Uncontrolled</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Head circumference growth</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 2SD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 3SD</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 4SD</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Thrive</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild FTT</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate FTT</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sever FTT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Hand use</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Proper</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Grasping</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moving toward</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Disable</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Communication abilities</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Proper</td>
<td align="left" colspan="1" rowspan="1" valign="middle"></td>
<td align="left" colspan="1" rowspan="1" valign="middle"></td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Autonomic system disorders</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Cold hands</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Cold hands and feet</td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EEG</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate abnormal</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Severe abnormal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Scoliosis </td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Severe</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Self abuse</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Occasional</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Usual</td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Signs and symptoms for each patient</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">
<bold>Patient number</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Thrive</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Psychomotor regression</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Head growth</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Locomotion</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>communication</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Autonomic dysfunction</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Hand use</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Self abuse</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>seizure</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>EEG</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Scoliosis</bold>
</th>
<th align="left" colspan="1" rowspan="1">
<bold>Genetic mutation</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">N<sup>*</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y<sup>**</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">N</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">++</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">+++</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">+</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">Y</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>* N stands for patients without genetic mutation ** Y stands for patients with genetic mutation</p>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Frequency of severity of signs and symptoms</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="middle"></th>
<th align="left" colspan="1" rowspan="1" valign="middle">Description</th>
<th align="left" colspan="1" rowspan="1">Number (percent)</th>
<th align="left" colspan="1" rowspan="1" valign="middle">Description</th>
<th align="left" colspan="1" rowspan="1">Number(percent)</th>
<th align="left" colspan="1" rowspan="1" valign="middle">Description</th>
<th align="left" colspan="1" rowspan="1">Number (percent)</th>
<th align="left" colspan="1" rowspan="1" valign="middle">Description</th>
<th align="left" colspan="1" rowspan="1">Number (percent)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Locomotion (walking)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Without help</td>
<td align="left" colspan="1" rowspan="1">3(13%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">With help</td>
<td align="left" colspan="1" rowspan="1">12(52.2%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">With device</td>
<td align="left" colspan="1" rowspan="1">4(17.4%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Disable to walk</td>
<td align="left" colspan="1" rowspan="1">4(17.4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Seizure</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1">5(21.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Under control</td>
<td align="left" colspan="1" rowspan="1">9(39.1%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Partially controlled</td>
<td align="left" colspan="1" rowspan="1">4(17.4%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">uncontrolled</td>
<td align="left" colspan="1" rowspan="1">5(21.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Head circumference growth</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1">3(13%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 2SD</td>
<td align="left" colspan="1" rowspan="1">15(65.2%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 3SD</td>
<td align="left" colspan="1" rowspan="1">4(17.4%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Less than 4SD</td>
<td align="left" colspan="1" rowspan="1">1(4.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Thrive</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1">15(65.2%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild FTT</td>
<td align="left" colspan="1" rowspan="1">2(8.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate FTT</td>
<td align="left" colspan="1" rowspan="1">6(26.1%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sever FTT</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Hand use</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Proper</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Grasping</td>
<td align="left" colspan="1" rowspan="1">13(56.5%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moving toward</td>
<td align="left" colspan="1" rowspan="1">9(39.1%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Disable</td>
<td align="left" colspan="1" rowspan="1">1(4.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Communication abilities</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Proper</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1" valign="middle"></td>
<td align="left" colspan="1" rowspan="1">16(69.6%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle"></td>
<td align="left" colspan="1" rowspan="1">7(30.4%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Autonomic system disorders</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1">16(69.6%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Cold hands</td>
<td align="left" colspan="1" rowspan="1">5(21.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Cold hands and feet</td>
<td align="left" colspan="1" rowspan="1">2(8.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">EEG</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Normal</td>
<td align="left" colspan="1" rowspan="1">8(34.8%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild abnormal</td>
<td align="left" colspan="1" rowspan="1">4(17.4%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate abnormal</td>
<td align="left" colspan="1" rowspan="1">6(26.1%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Severe abnormal</td>
<td align="left" colspan="1" rowspan="1">5(21.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Scoliosis </td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1">17(73.9%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Mild</td>
<td align="left" colspan="1" rowspan="1">5(21.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Moderate</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Severe</td>
<td align="left" colspan="1" rowspan="1">1(4.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Self abuse</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1">11(47.8%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Occasional</td>
<td align="left" colspan="1" rowspan="1">10(43.5%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Usual</td>
<td align="left" colspan="1" rowspan="1">2(8.7%)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">-</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table 5</label>
<caption>
<p>Gene mutation was studied for each patient</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Patient’s number</th>
<th align="left" colspan="1" rowspan="1">Nucleotide change</th>
<th align="left" colspan="1" rowspan="1">Amino acid change</th>
<th align="left" colspan="1" rowspan="1">Type of seq. change</th>
<th align="left" colspan="1" rowspan="1">References</th>
<th align="left" colspan="1" rowspan="1">Figure</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">c.750_750delCinsTCAGGAAGCTT</td>
<td align="left" colspan="1" rowspan="1">p.P251fs</td>
<td align="left" colspan="1" rowspan="1">Frame shift combined insertion and deletion</td>
<td align="left" colspan="1" rowspan="1">(24)</td>
<td align="left" colspan="1" rowspan="1">1A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="left" colspan="1" rowspan="1">c.763C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R255X</td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">(25-33)</td>
<td align="left" colspan="1" rowspan="1">1B</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2,14,22</td>
<td align="left" colspan="1" rowspan="1">c.862G&gt;A</td>
<td align="left" colspan="1" rowspan="1">p.V288M</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">(34)</td>
<td align="left" colspan="1" rowspan="1">1C</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="1">c.468C&gt;G</td>
<td align="left" colspan="1" rowspan="1">p.D156E</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">(35-41)</td>
<td align="left" colspan="1" rowspan="1">1D</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1">c.880C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R294X</td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">(18, 25-31, 42)</td>
<td align="left" colspan="1" rowspan="1">1E</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">c.473C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.T158M</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">(18, 25-30, 42)</td>
<td align="left" colspan="1" rowspan="1">1F</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">c.397C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R133C</td>
<td align="left" colspan="1" rowspan="1">Missense</td>
<td align="left" colspan="1" rowspan="1">(4, 17, 25, 26, 29-31, 36, 37, 42-55)</td>
<td align="left" colspan="1" rowspan="1">1G</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">c.502C&gt;T</td>
<td align="left" colspan="1" rowspan="1">p.R168X</td>
<td align="left" colspan="1" rowspan="1">Nonsense</td>
<td align="left" colspan="1" rowspan="1">(17, 18, 24-32, 37, 38, 42, 43, 45-49, 53-57)</td>
<td align="left" colspan="1" rowspan="1">1H</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Electrophoretogram of patients. Refer to the text and <xref ref-type="table" rid="T5">Table 5</xref> for an explanation of the details of each mutation</p>
</caption>
<graphic xlink:href="ijcn-13-037-g001"></graphic>
</fig>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In this study, we reported the results of mutational analysis for <italic>MECP2</italic> gene in Iranian affected RTT girls. To our knowledge, this was the first time that Rett patients were studied in both clinical manifestations and genetic changes in Iran. About 47% of patients participated in our study showed <italic>MECP2</italic> mutation including missense, nonsense or frame shift.</p>
<p>The rate of mutation detection in our study is equal to some previously reported rates such as the 50% detection rate. It confirms the major role of <italic>MECP2</italic> gene mutation in etiology of Iranian patients too (<xref ref-type="bibr" rid="B16">16</xref>). On the other hand, there is a difference comparing to findings of another study where nearly 70%-80% of females with Rett’s syndrome had these mutations within the <italic>MECP2</italic> gene (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Of note, <italic>MECP2</italic> positivity differs in various countries, as De novo mutations were found in 60% of the patients in Spain which is closer to our findings (<xref ref-type="bibr" rid="B17">17</xref>). This difference is also referred to the limited number of patients studied in such studies and a series of patient who refused to participate like happened in our research. This reason could explain when comparing the results of a study in Japan in which 19 disease mutations (73%) were identified in 26 Japanese Rett patients (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>The mutational diversity in our patients is consistent with the findings of other studies (<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>). In our study, about 10% of mutations were intragenic deletions or complex rearrangements that lead to frameshifts. In our study, of 10 <italic>MECP2</italic> positive mutations, we detected one case with frameshift in the C-terminal region. </p>
<p>Moreover, the majority of mutations was C&gt;T transitions which were nearly 70% of all identified mutations. Similarly, the majority of mutations in our study was C&gt;T transitions too which was about 50% in another study (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>The p.V288M amino acid change is identified as the most common mutational hotspot in our study. However, this mutation is not included in common formerly recognized hot spots. This is a new finding in patients with Rett syndrome in Iranian population.</p>
<p>In a previous study, 70% of the mutations within MECP2 were in eight hotspots which affect translation of the amino acids including R106, R133, T158, R168, R255, R270, R294, and R306 (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>According to patients’ signs and symptoms, despite in some items like epilepsy and EEG abnormalities, <italic>MECP2</italic> positives showed slightly higher rates compared to those without mutations, and autonomic dysfunctions were more seen in <italic>MECP2</italic> negatives, but none of them revealed significant correlation between signs and mutations. Moreover, severity of signs and symptoms is not in relation with gene mutation and loci of mutation in our research. The only exception refers to sever EEG abnormality seen in patients with p.V288M amino acid change. </p>
<p>Location and frequency of <italic>MeCP2</italic> ‘‘hotspot’’ mutations in RTT patients show that most of these mutations are point substitutes in nucleotides including R106W, arginine to tryptophan point mutation at residue 106; R133C, arginine to cysteine point mutation at residue 133; T158M, threonine to methionine point mutation at residue 158; R168X, arginine to stop codon at residue 168; R255X, arginine to stop codon at residue 255; R294X, arginine to stop codon at residue 294; R306C, arginine to cysteine point mutation at residue 306. The amino acids 207and 310 of TRD are involved in the repression of transcription of target genes, but the mechanism of TRD repression is unknown (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>The study of genotype-phenotype correlation requires precise investigations in larger group of patients to determine correlation with various types of mutations.</p>
<p>Genotype-phenotype correlation has been investigated, but it is complex by <italic>MECP2</italic> gene X-chromosome inactivation. This inactivity allows a mother with a mutation of MECP2 to have a normal phenotype because of skewing of X-chromosome inactivation (<xref ref-type="bibr" rid="B22">22</xref>). In contrast to the problems with X-chromosome inactivation, many studies of genotype-phenotype correlations exist (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). More studies must be carried out to investigate more case to find better conclusions.</p>
<p>
<bold>In conclusion,</bold> our results together with data reported by others allow general conclusions about the MECP2 mutational spectrum and growth/developmental manifestations or phenotypes.</p>
</sec>
<sec>
<title>Author`s contribution</title>
<p>Parvaneh Karimzadeh: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work.</p>
<p>Majid Kheirollahi: Drafting the work or revising it critically for important intellectual content, final approval of the version to be published </p>
<p>Seyed Massoud Houshmand: Final approval of the version to be published.</p>
<p>Sepideh Dadgar: Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved</p>
<p>Omid Aryani: Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved</p>
<p>Omid Yaghini: Drafting the work or revising it critically for important intellectual content, final approval of the version to be published (ORCID ID</p>
<p>All authors agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgment</title>
<p>We thank all patients and their families participating in this project.</p>
</ack>
<sec sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that there is no conflict of interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rett</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>On a unusual brain atrophy syndrome in hyperammonemia in childhood</article-title>
<source/> Wien Med Wochenschr
          <year>1996</year>
<volume>116</volume>
<issue>37</issue>
<fpage>723</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percy</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The American History of Rett Syndrome</article-title>
<source/> Pediatr Neurol
          <year>2014</year>
<volume>50</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">24200039</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="webpage">
<collab>Medline Plus</collab>
<source/>Rett syndrome
          <year>2012</year>
<date-in-citation>Retrieved May 10, 2012</date-in-citation>
<comment> from <ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/medlineplus/ency/article/001536.htm">http://www.nlm.nih.gov/medlineplus/ency/article/001536.htm</ext-link></comment>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van-den-Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/> Nat Genet
          <year>1999</year>
<volume>23</volume>
<fpage>185</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van</surname>
<given-names>den Veyver IB</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Genetic basis of Rett syndrome</article-title>
<source/> Ment Retard Dev Disabil Res Rev
          <year>2002</year>
<volume>8</volume>
<issue>2</issue>
<fpage>82</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">12112732</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>MeCP2 dysfunction in Rett syndrome and related disorders</article-title>
<source/> Curr Opin Genet Dev
          <year>2006</year>
<volume>16</volume>
<fpage>276</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">16647848</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome</article-title>
<source/> Brain Dev
          <year>2001</year>
<volume>Suppl 1</volume>
<fpage>S32</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakefield</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Free</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Soteriou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uhrin</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The solution structure of the domain from MeCP2 that binds to methylated DNA</article-title>
<source/> J Mol Biol
          <year>1999</year>
<volume>291</volume>
<issue>5</issue>
<fpage>1055</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">10518942</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Childers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Annese</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Barrish</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Rett syndrome: North American database</article-title>
<source/> J Child Neurol
          <year>2007</year>
<volume>22</volume>
<fpage>1338</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">18174548</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>Esch H</given-names>
</name>
<name>
<surname>Hagedorn-Greiwe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mutations in theX-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) geneare associated with severe neurodevelopmental retardation</article-title>
<source/> Am J Hum Genet
          <year>2004</year>
<volume>75</volume>
<fpage>1149</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">15499549</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaving</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Friend</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>OL</given-names>
</name>
<name>
<surname>Archer</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantilespasms and mental retardation</article-title>
<source/> Am J Hum Genet
          <year>2004</year>
<volume>75</volume>
<fpage>1079</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">15492925</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Archer</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Colley</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Ravn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Early onset seizures and Rettlikefeatures associated with mutations in CDKL5</article-title>
<source/> Eur J Hum Genet
          <year>2005</year>
<volume>13</volume>
<fpage>1113</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">16015284</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scala</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ariani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>CDKL5/STK9 is mutated in Rettsyndrome variant with infantile spasms</article-title>
<source/> J Med Genet
          <year>2005</year>
<volume>42</volume>
<fpage>103</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">15689447</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scala</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ariani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Caselli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pescucci</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Disruption of Netrin G1 by abalanced chromosome translocation in a girl with Rettsyndrome</article-title>
<source/> Eur J Hum Genet
          <year>2005</year>
<volume>13</volume>
<fpage>921</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">15870826</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett syndrome: revised diagnostic criteria and nomenclature</article-title>
<source/> Ann Neurol
          <year>2010</year>
<volume>68</volume>
<fpage>944</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">21154482</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SSJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Houwink-Manville</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots</article-title>
<source/> Am J Hum Genet
          <year>1999</year>
<volume>65</volume>
<fpage>1520</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">10577905</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monrós</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Aibar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Canós</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pineda</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Rett syndrome in Spain: mutation analysis and clinical correlations</article-title>
<source/> Brain Dev
          <year>2001</year>
<volume>Suppl 1</volume>
<fpage>S251</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Segawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamakawa</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome</article-title>
<source/> J Hum Genet
          <year>2000</year>
<volume>45</volume>
<issue>4</issue>
<fpage>231</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">10944854</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Spectrum of MECP2 mutations in Rett syndrome</article-title>
<source/> . Brain &amp; Development
          <year>2001</year>
<volume>23</volume>
<fpage>S138</fpage>
<lpage>S43</lpage>
<pub-id pub-id-type="pmid">11738860</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Youssoufian</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The CpG dinucleotide and human genetic disease</article-title>
<source/> Hum Genet
          <year>1988</year>
<volume>78</volume>
<issue>2</issue>
<fpage>151</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">3338800</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adkins</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Georgel</surname>
<given-names>PT</given-names>
</name>
</person-group>
<article-title>MeCP2: structure and function</article-title>
<source/> Biochem Cell Biol
          <year>2011</year>
<volume>89</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">21326358</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>den Veyver I</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Malicki</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Dahle</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<article-title>Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes</article-title>
<source/> Ann Neurol
          <year>2000</year>
<volume>47</volume>
<fpage>670</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">10805343</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheadle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maynard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location</article-title>
<source/> Hum Mol Genet
          <year>2000</year>
<volume>9</volume>
<fpage>1119</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">10767337</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>KY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome</article-title>
<source/> J Med Genet
          <year>2000</year>
<volume>37</volume>
<issue>12</issue>
<fpage>1377</fpage>
<lpage>1384</lpage>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffbuhr</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Devaney</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>LaFleur</surname>
<given-names>B</given-names>
</name>
<name>
<surname>SirianniN</surname>
<given-names></given-names>
</name>
<name>
<surname>Scacheri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Giron</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MeCP2 mutationsin children with and without the phenotype of Rett syndrome</article-title>
<source/> Neurology
          <year>2001</year>
<volume>56</volume>
<issue>11</issue>
<fpage>1486</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">11402105</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Krämer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients</article-title>
<source/> Hum Mol Genet
          <year>2000</year>
<volume>9</volume>
<issue>9</issue>
<fpage>1369</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">10814718</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hampson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Latif</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Mutations in the MECP2 gene in a cohort of girls with Rett syndrome</article-title>
<source/> J Med Genet
          <year>2000</year>
<volume>37</volume>
<issue>8</issue>
<fpage>610</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="pmid">10991689</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bourdon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Labrune</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Amsallem</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arnould</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jonveaux</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rettsyndrome patients</article-title>
<source/> Hum Genet
          <year>2001</year>
<volume>108</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">11214906</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trappe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cobilanschi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 mutations in sporadic cases of Rett syndrome are almostexclusively of paternal origin</article-title>
<source/> Am J Hum Genet
          <year>2001</year>
<volume>68</volume>
<issue>5</issue>
<fpage>1093</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">11309679</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auranen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vanhala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vosman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levander</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varilo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hietala</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features</article-title>
<source/> Neurology
          <year>2001</year>
<volume>56</volume>
<issue>5</issue>
<fpage>611</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">11245712</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De</surname>
<given-names>Bona C</given-names>
</name>
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Vitelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bruttini</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preserved speech variant is allelic of classic Rett syndrome</article-title>
<source/> Eur J Hum Genet
          <year>2000</year>
<volume>8</volume>
<issue>5</issue>
<fpage>325</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">10854091</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orrico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dotti</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>SF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 mutation in male patients with non-specific X-linked mental retardation</article-title>
<source/> FEBS Lett
          <year>2000</year>
<volume>481</volume>
<issue>3</issue>
<fpage>285</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">11007980</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellaway</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Badawi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Raffaele</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A case of multiple congenital anomalies in association with Rett syndromeconfirmed by MECP2 mutation screening</article-title>
<source/> Clin Dysmorphol
          <year>2001</year>
<volume>10</volume>
<issue>3</issue>
<fpage>185</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">11446411</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="webpage">
<source/>CCHMC Molecular Genetics Laboratory Mutation Database
          <year>2018</year>
<comment><ext-link ext-link-type="uri" xlink:href="https://research.cchmc.org/LOVD2/variants.php?select_db=MECP2&amp;amp;action=view&amp;amp;view=0000402%2C0000111%2C0">https://research.cchmc.org/LOVD2/variants.php?select_db=MECP2&amp;amp;action=view&amp;amp;view=0000402%2C0000111%2C0</ext-link> [database on the Internet]</comment>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Held</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Engel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Influence of mutation type and location on phenotype in 123 patients with Rett syndrome</article-title>
<source/> Neuropediatrics
          <year>2002</year>
<volume>33</volume>
<issue>2</issue>
<fpage>63</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">12075485</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kumagai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation</article-title>
<source/> Hum Mutat
          <year>2001</year>
<volume>18</volume>
<issue>3</issue>
<fpage>18</fpage>
<lpage>253</lpage>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Philippe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Villard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Roux N</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bonnefond</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Pasquier</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update</article-title>
<source/> Eur J Med Genet
          <year>2006</year>
<volume>49</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">16473305</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bienvenu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Villard</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Roux N</given-names>
</name>
<name>
<surname>Bourdon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fontes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Beldjord</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spectrum of MECP2 mutations in Rett syndrome</article-title>
<source/> Genet Test
          <year>2002</year>
<volume>6</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">12180070</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Brunoni</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schwartzman</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Pozzi</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kok</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Juliano</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genotype-phenotype correlation in Brazillian Rett syndrome patients</article-title>
<source/> Arq Neuropsiquiatr
          <year>2009</year>
<volume>67</volume>
<issue>3A</issue>
<fpage>577</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">19722030</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raizis</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>MacKay</surname>
<given-names>R</given-names>
</name>
<name>
<surname>George</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Spectrum of MECP2 mutations in New Zealand Rett syndrome patients</article-title>
<source/> N Z Med J
          <year>2009</year>
<volume>122</volume>
<issue>1296</issue>
<fpage>21</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Psoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sofocleous</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Traeger-Synodinos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kitsiou-Tzeli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kanavakis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fryssira-KaniouraH</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders</article-title>
<source/> Brain Dev
          <year>2012</year>
<volume>34</volume>
<issue>6</issue>
<fpage>487</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="pmid">21982064</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsuishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kuwajima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Horiuchi</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome</article-title>
<source/> J Med Genet
          <year>2000</year>
<volume>37</volume>
<issue>8</issue>
<fpage>608</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">10991688</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buyse</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hoon</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Roa</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms</article-title>
<source/> Am J Hum Genet
          <year>2000</year>
<volume>67</volume>
<issue>6</issue>
<fpage>1428</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">11055898</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Renieri</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Preserved speech variants of the Rett syndrome: molecular and clinical analysis</article-title>
<source/> Am J Med Genet
          <year>2001</year>
<volume>104</volume>
<issue>1</issue>
<fpage>14</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">11746022</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erlandson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hallberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wahlström</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinsson</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>MECP2 mutation screening in Swedish classical Rett syndrome females</article-title>
<source/> EurChild Adolesc Psychiatry
          <year>2001</year>
<volume>10</volume>
<issue>2</issue>
<fpage>117</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meins</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions</article-title>
<source/> Hum Mutat
          <year>2001</year>
<volume>17</volume>
<issue>3</issue>
<fpage>183</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">11241840</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>4icolao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Giometto</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tavolato</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cattin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Giovannucci-Uzielli</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DHPLC analysis of the MECP2 gene in Italian Rett patients</article-title>
<source/> Hum Mutat
          <year>2001</year>
<volume>18</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">11462237</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>acca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Filippini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Budillon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mercadante</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Manzati</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females</article-title>
<source/> J Mol Med (Berl)
          <year>2001</year>
<volume>78</volume>
<issue>1</issue>
<fpage>648</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">11269512</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schanen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Houwink</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Dorrani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Everett</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome</article-title>
<source/> Am J Med Genet A
          <year>2004</year>
<volume>126A</volume>
<issue>2</issue>
<fpage>129</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">15057977</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masuyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsuo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Tabara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kitsuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Classic Rett syndrome in a boy with R133C mutation of MECP2</article-title>
<source/> Brain Dev
          <year>2005</year>
<volume>27</volume>
<issue>6</issue>
<fpage>439</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">16122633</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Canitano</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rosaia</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Study of MECP2 gene in Rett syndrome variants and autistic girls</article-title>
<source/> Am J Med Genet B Neuropsychiatr Genet
          <year>2003</year>
<volume>119B</volume>
<issue>1</issue>
<fpage>102</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">12707946</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yntema</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Mullaart</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Geerdink</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics</article-title>
<source/> Eur J Hum Genet
          <year>2004</year>
<volume>12</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">14560307</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matijević</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Knezević</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barisić</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Resić</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Culić</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pavelić</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The MECP2 gene mutation screening in Rett syndrome patients from Croatia</article-title>
<source/> Ann N Y Acad Sci
          <year>2006</year>
<volume>1091</volume>
<fpage>225</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="pmid">17341617</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zahorakova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rosipal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hadac</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zumrova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bzduch</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Misovicova</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation analysis of the MECP2 gene in patients of Slavic origin with Rett syndrome: novel mutations and polymorphisms</article-title>
<source/> J Hum Genet
          <year>2007</year>
<volume>52</volume>
<issue>4</issue>
<fpage>342</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">17387578</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>KY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic and epileptic features in Rett syndrome</article-title>
<source/> Yonsei Med J
          <year>2012</year>
<volume>53</volume>
<issue>3</issue>
<fpage>495</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="pmid">22476991</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chae</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype</article-title>
<source/> J Child Neurol
          <year>2004</year>
<volume>19</volume>
<issue>7</issue>
<fpage>503</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">15526954</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Stenbom</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Anvret</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>MECP2 mutations in Swedish Rett syndrome clusters</article-title>
<source/> Clin Genet
          <year>2002</year>
<volume>61</volume>
<issue>5</issue>
<fpage>384</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">12081725</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>